- Home
- GRWG vs NTHI Comparison
GRWG vs NTHI Comparison
Compare GRWG & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRWG | NTHI |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.6M | 106.0M |
| IPO Year | 2015 | 2023 |
Fundamental Metrics
Financial Performance| Metric | GRWG | NTHI |
|---|---|---|
| Price | $1.27 | $4.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $2.50 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 283.3K | 141.6K |
| Earning Date | 11-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.22 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $193,365,479.00 | $39,990.00 |
| Revenue This Year | $2.33 | N/A |
| Revenue Next Year | $3.82 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 142.51 | N/A |
| 52 Week Low | $1.01 | $2.50 |
| 52 Week High | $2.40 | $11.38 |
Technical Indicators
Market Signals| Indicator | GRWG | NTHI |
|---|---|---|
| Relative Strength Index (RSI) | 31.19 | 73.82 |
| Support Level | $1.04 | $4.18 |
| Resistance Level | $1.58 | $4.59 |
| Average True Range (ATR) | 0.08 | 0.41 |
| MACD | -0.01 | 0.18 |
| Stochastic Oscillator | 30.43 | 84.32 |
Price Performance
Historical ComparisonAbout GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail stores focused on hydroponic and organic gardening. The company markets and distributes nutrients, growing media, indoor and greenhouse lighting, ventilation systems, and related accessories. It operates through two reportable segments: Cultivation and Gardening, which includes its hydroponic and organic gardening business, and Storage Solutions, which includes its benching, racking, and storage solutions operations. The company generates revenue mainly from the sale of proprietary and non-proprietary products through retail stores, e-commerce platforms, wholesale distribution, and commercial sales, along with the sale and installation of commercial fixtures.
About NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.